Wave Life Sciences (WVE) Equity Average (2016 - 2025)
Wave Life Sciences (WVE) has disclosed Equity Average for 11 consecutive years, with $321.5 million as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Equity Average rose 83.08% year-over-year to $321.5 million, compared with a TTM value of $321.5 million through Dec 2025, up 83.08%, and an annual FY2025 reading of $363.9 million, up 192.15% over the prior year.
- Equity Average was $321.5 million for Q4 2025 at Wave Life Sciences, up from $131.9 million in the prior quarter.
- Across five years, Equity Average topped out at $321.5 million in Q4 2025 and bottomed at -$46.1 million in Q3 2023.
- Average Equity Average over 5 years is $57.0 million, with a median of $28.5 million recorded in 2021.
- The sharpest move saw Equity Average tumbled 448.9% in 2023, then soared 41122.78% in 2024.
- Year by year, Equity Average stood at $31.2 million in 2021, then plummeted by 179.5% to -$24.8 million in 2022, then soared by 98.27% to -$428000.0 in 2023, then skyrocketed by 41122.78% to $175.6 million in 2024, then surged by 83.08% to $321.5 million in 2025.
- Business Quant data shows Equity Average for WVE at $321.5 million in Q4 2025, $131.9 million in Q3 2025, and $155.5 million in Q2 2025.